Vacuum Blood Collection Tube Patents: Who Leads and Where Filing Is Headed
53.2% concentration at the top. The five leading assignees hold 968 of the 1,821 records in scope, with a long tail of smaller filers behind them. Filings ran from 73 in 2017 to a peak of 95 in 2019, then fell to 24 by 2024 (-73% from 2021's 88). 2025 and 2026 are still filling in as publication catches up with filing, so the most recent two years should not be read as a real decline yet.
- 1BECTON DICKINSON & CO450
- 2SIO2 MEDICAL PRODUCTS INC239
- 3BIOVERATIV THERAPEUTICS INC99
- 4SIO2 MEDICAL PRODUCTS LLC92
- 5ABBOTT LAB INC88
See the full vacuum blood collection tubes analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on this landscape
Who holds the most patents on vacuum blood collection tubes?
Filing in this dataset is concentrated at the top: the leading assignee holds 450 of the 1,821 records in scope, and the five leading assignees combined account for 53.2% of all records. That concentration extends to ten assignees, who together hold 64.6% of the field. Below that top tier, filing spreads across a long tail of smaller and single-filing entrants, so freedom-to-operate work should prioritise the leading names first but not stop there.
Is the vacuum blood collection tube patent field still growing?
Filing volume peaked in 2019 at 95 records and has since fallen, with the 2021-to-2024 span showing a 73% drop from 88 to 24 filings. That looks like a slowdown, but publication lags filing by roughly 18 months, so 2025 and 2026 figures are still incomplete and should not be read as evidence of continued decline. 2024 is the most recent year that can be treated as a complete data point.
What technology areas dominate vacuum blood collection tube patents?
Material analysis and testing (IPC class G01N) appears in 30.0% of the 1,821 records, the largest single class, followed by lab apparatus (B01L) at 26.4% and diagnosis and surgery devices (A61B) at 23.4%. Coating and surface deposition (C23C), the class covering barrier and additive-protective coatings, sits lower at 15.9% but is where some of the most cited and commercially referenced filings sit. Because a single record can carry several IPC classes, these figures do not sum to 100% and should be read as independent shares of the same 1,821-record base.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Vacuum Blood Collection Tubes covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.